30/SEP/14
Taper and Neuron Bio partner for sale of R&D services
Neuron Bio has reached a strategic agreement with the company Taper aimed to enhance its commercial activities.
Taper is one of main health and science technology suppliers in Spain and Portugal with a portfolio of over 3,000 clients and a turnover of over €25 million in 2013.
Neuron Bio, via its division Neuron BioServices has signed a commercialization agreement related to a range of research and development services with the company Taper, who will be in charge of these commercial activities in Spain in Portugal through its consolidated commercial network.
Neuron Bio brings to the alliance its know-how in the field of research, its researcher and manager team, as well as its top-level facilities and laboratories. Meanwhile, Taper brings its experienced commercial team build up by over 80 professionals, as well as its client port-folio in the science and health sector. The alliance between both companies enables Taper to offer R&D services developed by Neuron BioServices thus Neuron Bio enhances its commercial capacity.
Representatives of both companies valued very positively the reached agreement and are confident that it will lead to productive results in the short medium term.
About Neuron Bio
NEURON BIO (ticker: NEU) is a biotechnological company quoted on the Alternative Stock Market MAB that develops biosolutions with application to the pharmaceutical and agro-food industries and commercializes its services through its division NEURON BIOSERVICES.
NEURON BIO mainly focuses in the search of drugs for the prevention and treatment of neurodegenerative diseases, especially the Alzheimer’s disease, as well as the development of non-invasive diagnosis tools that allow more efficiently determining the progress of this disease.
NEURON BIOSERVICES has a range of comprehensive services for the development of projects and research facilities for public entities, pharmaceutical, biotechnological, agro-food and animal health companies offering consultancy and preclinical services.
The company was founded in 2005 as a spin-off of the research group from Dr. Fernando Valdivieso, Professor of molecular biology of the Madrid Autonomous University. In little more than 8 years, NEURON BIO has become a reference business project in the Spanish biotechnological sector supported by numerous national and international honors and awards.
Neuron Bio has research laboratories in Madrid and in Granada.
About Taper
TAPER was created in Spain in 1989 as the result of a merger process of various regional companies dedicated to the distribution of medical products. Over the years the company added business leaders in each of its sectors: PACISA (instrumentation and reagents for laboratories), GIRALT (equipments for anatomical pathology and life sciences), PROGENETICS (reagents for use in molecular biology), DISSA (electromedicine), ENDOSCOPIA MÉDICA (rigid endoscopy) and LA CASA DEL MÉDICO (ophthalmology, rehabilitation and general supplies for clinics).
In 2004 it was created TAPER Portugal with the acquisition of HITEC EQUIPAMENTOS (medical and laboratory instrumentation) and later BIOCITEC (scientific equipment).
In 2014 TAPER acquires CYMIT QUÍMICA an online sales platform specializing in chemical reagents for pharmaceutical and research laboratories. The company begins trading under its own trade mark with high-quality and low-cost products for each type of laboratories.
A success story and over 25 years of accumulated experience makes of Grupo Taper one of the first and main suppliers of health and science technologies chosen by professionals of the Spanish and Portuguese sanitary system, as well as by scientists, researchers and responsible of quality in the food industry.
|